The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
47
Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.EBI
University of North Carolina at Chapel Hill
8
Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7.EBI
Icahn School Of Medicine At Mount Sinai
7
Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.EBI
University of Victoria
63
Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).EBI
University of Victoria
60
Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.EBI
University of North Carolina at Chapel Hill
4
Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain.EBI
University of North Carolina Eshelman School of Pharmacy
12
Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins.EBI
University of Victoria
7
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).EBI
Icahn School Of Medicine At Mount Sinai
61
Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL.EBI
Peking University
25
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.EBI
University of North Carolina
33
Methyllysine binding domains: Structural insight and small molecule probe development.EBI
University of Connecticut
27
AAK1 INHIBITOR AND USE THEREOFBDB
Xizang Haisco Pharmaceutical
8
In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.BDB
Whitby Research